BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/11/2025 9:45:46 AM | Browse: 1031 | Download: 538
 |
Received |
|
2025-05-21 06:09 |
 |
Peer-Review Started |
|
2025-05-22 00:06 |
 |
First Decision by Editorial Office Director |
|
2025-06-06 03:28 |
 |
Return for Revision |
|
2025-06-06 03:28 |
 |
Revised |
|
2025-06-14 18:39 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-08-06 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-08-06 04:08 |
 |
Articles in Press |
|
2025-08-06 04:08 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-09-03 01:00 |
 |
Publish the Manuscript Online |
|
2025-09-11 09:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
Targeting Ras homolog enriched in brain 1 to restore β-cell mass and function: A potential therapeutic strategy for diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yao Peng, Dong-Dong Zhang, Ling Gan and Jia-Qi Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hubei Provincial Natural Science Foundation |
2025AFB845 |
| Graduate Innovation and Entrepreneurship Fund of Wuhan University of Science and Technology |
JCX2024044 |
|
| Corresponding Author |
Jia-Qi Zhang, Associate Professor, MD, PhD, Department of Ultrasound Imaging, Postgraduate Union Training Base of Xiangyang No. 1 People’s Hospital, School of Medicine, Wuhan University of Science and Technology, No. 15 Jiefang Road, Fancheng District, Xiangyang 441000, Hubei Province, China. 347235272@qq.com |
| Key Words |
Diabetes mellitus; β cell dysfunction; Ras homolog enriched in brain 1; Mechanistic target of rapamycin complex 1 pathway; AMP-activated protein kinase pathway; Hepatocyte nuclear factor 4 alpha |
| Core Tip |
Dysregulation of β-cell mass and function contributes to the development and progression of diabetes mellitus. In a recent study, Yang et al identified Ras homolog enriched in brain 1 (Rheb1) as a critical regulator of β-cell proliferation via both mechanistic target of rapamycin complex 1 and AMP-activated protein kinase signaling pathways. Rheb1 also enhances hepatocyte nuclear factor 4 alpha expression, further supporting its role in maintaining β-cell functionality. These results reveal an intricate signaling network through by Rheb1 supports β-cell growth and survival, highlighting its potential as a therapeutic target for diabetes management. Further research is warranted to explore the translational applications of these findings. |
| Publish Date |
2025-09-11 09:41 |
| Citation |
Peng Y, Zhang DD, Gan L, Zhang JQ. Targeting Ras homolog enriched in brain 1 to restore β-cell mass and function: A potential therapeutic strategy for diabetes. World J Diabetes 2025; 16(9): 109768 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i9/109768.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i9.109768 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.